All Curated Mutation Sites in HCMV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCMV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: UL89

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38880196	D344E	UL89	UL89	Cytomegalovirus infections		View
2	38880196	D344Y	UL89	UL89	Cytomegalovirus infections		View
3	9420278	A355T	UL89	UL89	Cell line	D R	View
4	9420278	D344E	UL89	UL89	Cell line	D R	View
5	9573236	D344E	UL89	UL89	Cell line		View
6	25348532	A355T	UL89	UL89	Cell line	R	View
7	25348532	D344E	UL89	UL89	Cell line	R	View
8	25348532	E256Q	UL89	UL89	Cell line	D R	View
9	25348532	G766C	UL89	UL89	Cell line	D R	View
10	28827420	C347S	UL89	UL89	Cell line	D R	View
11	28827420	D344E	UL89	UL89	Cell line	D R	View
12	28827420	H389N	UL89	UL89	Cell line	D R	View
13	28827420	M359I	UL89	UL89	Cell line	D R	View
14	28827420	N320H	UL89	UL89	Cell line	D R	View
15	28827420	N329S	UL89	UL89	Cell line	D R	View
16	28827420	N405D	UL89	UL89	Cell line	D R	View
17	28827420	R351H	UL89	UL89	Cell line	D R	View
18	28827420	T350M	UL89	UL89	Cell line	D R	View
19	28827420	V362M	UL89	UL89	Cell line	D R	View
20	29107686	D344E	UL89	UL89	Cell line	D	View
21	29649495	A355T	UL89	UL89	Cell line	D	View
22	29649495	D344E	UL89	UL89	Cell line	D	View

Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.